Natera, Inc.
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as tw…
Medical - Diagnostics & Research
US, San Carlos [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 0.66 | 4.12 | 4.10 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 117.63 | 5.88 | 2.70 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 2.46 | 6.57 | 6.42 | |
| Cash | -0.81 | 7.31 | 7.37 | |
| Capex | -110.45 | -0.17 | -0.08 | |
| Free Cash Flow | -90.24 | 0.06 | -0.57 | |
| Revenue | 16.72 | 3.04 | 2.61 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 10.39 | 0.57 | 0.51 | |
| Operating Margin | 25.63 | -0.20 | -0.27 | |
| ROA | 14.02 | -0.05 | -0.05 | |
| ROE | 16.51 | -0.09 | -0.10 | |
| ROIC | 13.97 | -0.06 | -0.07 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of NTRA is permitted for members.
5
Growth
The "Growth Entry" for the Focus of NTRA is permitted for members.
6
Leverage & Liquidity